Related Experiment Video

Updated: Dec 29, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.6K

Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response

George S Scaria1, Betsy T Kren1, Mark A Klein1,2,3

  • 1Research Service, Minneapolis VA Health Care System, Minneapolis, MN 55417, USA.

Pharmaceuticals (Basel, Switzerland)
|February 9, 2020
PubMed

Insights

This study explored gene expression in pancreatic cancer, hepatocellular carcinoma, and mesothelioma. Findings highlight potential combination therapies targeting cell cycle and mitochondrial antioxidant pathways for these difficult-to-treat cancers.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Pancreatic cancer, hepatocellular carcinoma (HCC), and mesothelioma are aggressive, treatment-refractory malignancies with poor patient prognoses.
  • The Cancer Genome Atlas (TCGA) project provided genomic overviews, but deeper pathway interactions may be missed.
  • Targeting specific molecular pathways offers potential therapeutic strategies for refractory cancers.

Purpose of the Study:

  • To investigate correlations between mRNA expression of key genes in cell cycle and mitochondrial antioxidant defense pathways.
  • To identify potential therapeutic targets by analyzing TCGA Pan-Cancer datasets.
  • To explore novel combination treatment strategies for pancreatic cancer, HCC, and mesothelioma.

Main Methods:

  • Utilized cBioPortal to query TCGA Pan-Cancer datasets.
  • Analyzed mRNA expression correlations between cell cycle and mitochondrial antioxidant genes.
  • Focused on gene expression patterns in pancreatic cancer, HCC, and mesothelioma.

Main Results:

  • Identified significant correlations between specific genes in the cell cycle and mitochondrial antioxidant pathways.
  • These correlations suggest interconnectedness between cellular proliferation and oxidative stress defense mechanisms.
  • Data indicates potential for synergistic effects when targeting both pathways simultaneously.

Conclusions:

  • The identified gene expression correlations warrant further investigation.
  • Combination therapies targeting both cell cycle and mitochondrial antioxidant pathways show promise for pancreatic cancer, HCC, and mesothelioma.
  • This research supports the development of novel treatment strategies for these refractory cancers.
Keywords:
cell cyclegenomehepatocellular carcinomamesotheliomamitochondriapancreatic neoplasmsreactive oxygen species

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.2K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.1K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K